David Colborn

Vice President, Clinical Operations

David Colborn

David C. Colborn is Vice President of Clinical Operations at Navidea having previously served as Senior Director of Clinical Operations since joining the company in May of 2012. In this role, Mr. Colborn provides guidance and oversight to the operational implementation of all clinical trials at Navidea. His 25 year career in pharmaceutical and biotechnology drug development research spans preclinical, manufacturing, and clinical trial activities in the therapeutic areas of Oncology, Infectious Disease, and CNS including development of Zinecard®, Idamycin, Revlimid, Oxaliplatin, Elitek™, and Mozobil. Prior to joining Navidea, Dave was Vice President of Global Operations for Veeda Oncology, from 2007 – 2012. While at Veeda, Dave provided leadership in the planning, project management and operations of clinical oncology research services for pharmaceutical and biotech sponsors in the US and internationally.  Dave’s prior experience also includes roles at Prologue Research International, Columbus Community Clinical Oncology Program, The Ohio State University Comprehensive Cancer Center  and Pharmacia, Inc.  Mr. Colborn has a B.S. degree in Biochemistry from The Ohio State University.